ALC vs LEGN
Alcon Inc vs Legend Biotech Corporation — AI-powered side-by-side comparison
VS
LEGN
Legend Biotech Corporation
57
Buy
| Metric | ALC | LEGN |
|---|
| AI Score |
68
|
57
|
| Price |
$75.39
|
$21.83
|
| P/E Ratio |
45.39×
|
-16.05×
|
| ROE |
4.4%
|
-29.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
54.9%
|
55.0%
|
| Debt / Equity |
0.24×
|
0.40×
|
| Dividend Yield |
0.5%
|
0.0%
|
| RSI (14) |
73.4
|
63.1
|
| Beta |
0.703
|
0.369
|
| Expected Upside |
+11.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALC versus LEGN.
ALC leads by 11 points.
ALC scores 68/100 (Buy) versus LEGN at 57/100 (Buy).
ALC Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- RSI at 73 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
LEGN Committee View
50% agreement
4 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 37.0% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Price structure making lower highs and lower lows — Technical
- Price structure (HH_HL) contradicts the downtrend -- mixed signals — Technical
- Bollinger bandwidth of 37.0% signals elevated volatility — Risk